Track topics on Twitter Track topics that are important to you
6120 Windward Parkway, Suite 290
United States of America
ATLANTA, GA / ACCESSWIRE / November 26, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today a...
Co-founder Dan Myers Named Non-Executive Chairman Additional Changes to the Executive Team ATLANTA, GA / ACCESSWIRE / November 29, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader i...
Record Net Revenue of $11.1 Million in Q3 2018; U.S. Net Revenue up 20% Record U.S. End User Demand in Q3 2018 Net Loss and Adjusted EBITDA Loss Continue to Improve ATLANTA, GA / ACCESSWIRE / Nove...
Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves... ...
Alimera Sciences Inc ALIM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by Glo...
Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.
The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.
C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...
The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...
Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...
Our name, Alimera, is a loose combination of ancient Greek words with the intended meaning of "Day of Truth" and is founded on the underlying principles of honesty, integrity, responsibility, candor, ...
DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...
Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...
T.A. Sciences www.TASciences.com is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...
We have published hundreds of Alimera Sciences news stories on BioPortfolio along with dozens of Alimera Sciences Clinical Trials and PubMed Articles about Alimera Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alimera Sciences Companies in our database. You can also find out about relevant Alimera Sciences Drugs and Medications on this site too.